| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |